Skip to main content
. 2017 Jul 17;13:1744806917723789. doi: 10.1177/1744806917723789

Figure 3.

Figure 3.

N-Methyl-D-aspartate (NMDA)-evoked current responses in remifentanil and inhibitors treated dorsal horn neurons. Significant increases in NMDA peak current amplitude occurred with remifentanil exposure. There was a significant decrease in NMDA-evoked current after chelerythrine, KN93, and PD98059 treatment.*p < 0.05 versus time 0 in group Remi, #p < 0.05 group KN93 versus group Remi, &p < 0.05 group chelerythrine versus group Remi, ap < 0.05 group PD98059 versus group Remi.